3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Recurrence
1
Carcinoma, Non-Small-Cell Lung
1
Acrocephalosyndactylia
1
Interventions
pemigatinib
6
infigratinib
3
erdafitinib
2
derazantinib
2
Rogaratinib
2
pembrolizumab
1
lenvatinib
1
exemestane
1
brivanib
1
atezolizumab
1
Rabeprazole
1
Irinotecan
1
INCB 54828-101
1
Gemcitabine
1
Fulvestrant
1
E-3810
1
Drug Combinations
1
Carboplatin
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Acrocephalosyndactylia
×
INCB 54828-101
×
Clear all
NCT05253807
2025-08-05
FIGHT-210
Incyte Corporation
Phase 2
Completed
8 enrolled
13 charts